{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:02:26Z","timestamp":1765609346382},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,10,16]],"date-time":"2007-10-16T00:00:00Z","timestamp":1192492800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1038\/sj.bjc.6604037","type":"journal-article","created":{"date-parts":[[2007,10,16]],"date-time":"2007-10-16T13:34:00Z","timestamp":1192541640000},"page":"1404-1408","source":"Crossref","is-referenced-by-count":39,"title":["The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus"],"prefix":"10.1038","volume":"97","author":[{"given":"M","family":"Sarbia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"P\u00fchringer-Oppermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B L D M","family":"Br\u00fccher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,16]]},"reference":[{"key":"BF6604037_CR1","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.0.CO;2-H","volume":"91","author":"E Ancona","year":"2001","unstructured":"Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A (2001) Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 91: 2165\u20132174","journal-title":"Cancer"},{"key":"BF6604037_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimmer dissociation. Nature 421: 499\u2013506","journal-title":"Nature"},{"key":"BF6604037_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"J Bartkova","year":"2005","unstructured":"Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864\u2013870","journal-title":"Nature"},{"key":"BF6604037_CR4","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/cncr.11660","volume":"98","author":"K Becker","year":"2003","unstructured":"Becker K, Mueller JD, Schulmacher C, Ott K, Fink U, Busch R, Bottcher K, Siewert JR, Hofler H (2003) Histomorphology and regression grading in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98: 1521\u20131530","journal-title":"Cancer"},{"key":"BF6604037_CR5","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/cncr.21850","volume":"106","author":"BLDM Br\u00fccher","year":"2006","unstructured":"Br\u00fccher BLDM, Becker K, Lordick F, Fink U, Sarbia M, Stein H, Busch R, Zimmermann F, Molls M, Hofler H, Siewert JR (2006) The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Cancer 106: 2119\u20132127","journal-title":"Cancer"},{"key":"BF6604037_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1442-2050.2007.00648.x","volume":"20","author":"BLDM Br\u00fccher","year":"2007","unstructured":"Br\u00fccher BLDM, Sarbia M, Oestreicher E, Molls M, Burian M, Biemer E, Stein HJ (2007) Squamous cell carcinoma and Zenker diverticulum. Dis Esoph 20: 75\u201378","journal-title":"Dis Esoph"},{"key":"BF6604037_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ejso.2004.06.008","volume":"30","author":"BLDM Br\u00fccher","year":"2004","unstructured":"Br\u00fccher BLDM, Stein HJ, Zimmermann F, Werner M, Sarbia M, Busch R, Dittler HJ, Molls M, Fink U, Siewert JR (2004) Responders benefit from neoadjuvant RTx\/CTx in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol 30: 963\u2013971","journal-title":"Eur J Surg Oncol"},{"key":"BF6604037_CR8","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMra035010","volume":"349","author":"PC Enzinger","year":"2003","unstructured":"Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349: 2241\u20132252","journal-title":"N Engl J Med"},{"key":"BF6604037_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1006\/bbrc.1999.1611","volume":"264","author":"C Gao","year":"1999","unstructured":"Gao C, Nakajima T, Taya Y, Tsuchida N (1999) Activation of p53 in MDM2-overexpressing cells through phosphorylation. Biochem Biophys Res Commun 264: 860\u2013864","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6604037_CR10","first-page":"6461","volume":"9","author":"MK Gibson","year":"2003","unstructured":"Gibson MK, Abraham SC, Wu TT, Burtness B, Heitmiller RF, Heath E, Forastiere A (2003) Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy. Clin Cancer Res 9: 6461\u20136468","journal-title":"Clin Cancer Res"},{"key":"BF6604037_CR11","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/1097-0142(19940915)74:6<1693::AID-CNCR2820740609>3.0.CO;2-#","volume":"74","author":"K Hickey","year":"1994","unstructured":"Hickey K, Grehan D, Reid IM, O'Briain S, Walsh TN, Hennessy TP (1994) Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 74: 1693\u20131698","journal-title":"Cancer"},{"key":"BF6604037_CR12","first-page":"97","volume":"2","author":"DH Ilson","year":"2004","unstructured":"Ilson DH (2004) New developments in the treatment of esophageal cancer. Clin Adv Hematol Oncol 2: 97\u2013104","journal-title":"Clin Adv Hematol Oncol"},{"key":"BF6604037_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s005350170095","volume":"36","author":"T Ito","year":"2001","unstructured":"Ito T, Kaneko K, Makino R, Ito H, Konishi K, Kurahashi T, Kitahara T, Mitamura K (2001) Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy. J Gastroenterol 36: 303\u2013311","journal-title":"J Gastroenterol"},{"key":"BF6604037_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature03097","volume":"432","author":"MB Kastan","year":"2004","unstructured":"Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432: 316\u2013323","journal-title":"Nature"},{"key":"BF6604037_CR15","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/S0003-4975(99)01146-7","volume":"68","author":"MJ Krasna","year":"1999","unstructured":"Krasna MJ, Mao YS, Sonett JR, Tamura G, Jones R, Suntharalingam M, Meltzer SJ (1999) P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients. Ann Thorac Surg 68: 2021\u20132024, discussion 2024\u20132025","journal-title":"Ann Thorac Surg"},{"key":"BF6604037_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1378\/chest.116.suppl_3.463S","volume":"116","author":"T Lerut","year":"1999","unstructured":"Lerut T, Coosemans W, Leyn PD, Van Raemdonck D, Deneffe G, Decker G (1999) Treatment of esophageal carcinoma. Chest 116: 463\u2013465","journal-title":"Chest"},{"key":"BF6604037_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207\u2013214","journal-title":"Cancer"},{"key":"BF6604037_CR18","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/sj.bjc.6601976","volume":"91","author":"F Miyazono","year":"2004","unstructured":"Miyazono F, Metzger R, Warnecke-Eberz U, Baldus SE, Brabender J, Bollschweiler E, Doerfler W, Mueller RP, Dienes HP, Aikou T, Hoelscher AH, Schneider PM (2004) Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br J Cancer 91: 666\u2013672","journal-title":"Br J Cancer"},{"key":"BF6604037_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00432-006-0085-9","volume":"132","author":"F P\u00fchringer-Oppermann","year":"2006","unstructured":"P\u00fchringer-Oppermann F, Stahl M, Keller G, Sarbia M (2006) Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junction. J Cancer Res Clin Oncol 132: 433\u2013438","journal-title":"J Cancer Res Clin Oncol"},{"key":"BF6604037_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<7::AID-CNCR2>3.0.CO;2-R","volume":"83","author":"UJR Ribeiro","year":"1998","unstructured":"Ribeiro UJR, Finkelstein SD, Safatle-Ribeiro AV, Landreneau RJ, Clarke MR, Bakker A, Swalsky PA, Gooding WE, Posner MC (1998) P53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer 83: 7\u201318","journal-title":"Cancer"},{"key":"BF6604037_CR21","first-page":"2991","volume":"12","author":"M Sarbia","year":"1998","unstructured":"Sarbia M, Stahl M, Fink U, Willers R, Seeber S, Gabbert HE (1998) Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities. Clin Cancer Res 12: 2991\u20132997","journal-title":"Clin Cancer Res"},{"key":"BF6604037_CR22","first-page":"465","volume":"19","author":"JF Seitz","year":"1995","unstructured":"Seitz JF, Perrier H, Monges G, Giovannini M, Gouvernet J (1995) [Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53; in French. Gastroenterol Clin Biol 19: 465\u2013474","journal-title":"Gastroenterol Clin Biol"},{"key":"BF6604037_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","volume":"91","author":"SY Shieh","year":"1997","unstructured":"Shieh SY, Ikeda M, Taya Y, Prives C (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325\u2013334","journal-title":"Cell"},{"key":"BF6604037_CR24","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/sj.bjc.6600129","volume":"86","author":"H Shimada","year":"2002","unstructured":"Shimada H, Hoshino T, Okazumi S, Matsubara H, Funami Y, Nabeya Y, Hayashi H, Takeda A, Shiratori T, Uno T, Ito H, Ochiai T (2002) Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma. Br J Cancer 86: 552\u2013557","journal-title":"Br J Cancer"},{"key":"BF6604037_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00000658-200109000-00010","volume":"234","author":"JR Siewert","year":"2001","unstructured":"Siewert JR, Stein HJ, Feith M, Br\u00fccher BLDM, Bartels H, Fink U (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western world. Ann Surg 234: 360\u2013367","journal-title":"Ann Surg"},{"key":"BF6604037_CR26","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0959-8049(99)00172-0","volume":"35","author":"P Soontrapornchai","year":"1999","unstructured":"Soontrapornchai P, Elsaleh H, Joseph D, Hamdorf JM, House AK, Iacopetta B (1999) TP53 gene mutation status in pretreatment biopsies of oesophageal adenocarcinoma has no prognostic value. Eur J Cancer 35: 1683\u20131687","journal-title":"Eur J Cancer"},{"key":"BF6604037_CR27","volume-title":"TNM Classification of Malignant Tumours","author":"C Wittekind","year":"2002","unstructured":"Wittekind C, Meyer HJ, Bootz F (2002) TNM Classification of Malignant Tumours, 6th edn, Berlin: Springer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604037","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:29:35Z","timestamp":1684412975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,16]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["BF6604037"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604037","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,16]]}}}